These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6107241)

  • 1. Free somatostatin in the circulation: amounts and molecular sizes of somatostatin-like immunoreactivity in portal, aortic, and vena caval plasma of fasting and meal-stimulated dogs.
    Schusdziarra V; Zyznar E; Rouiller D; Harris V; Unger RH
    Endocrinology; 1980 Nov; 107(5):1572-6. PubMed ID: 6107241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Origin of peripheral venous hypersomatostatinemia in alloxan-diabetic dogs.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Endocrinology; 1981 Oct; 109(4):1107-16. PubMed ID: 6116595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin-like immunoreactivity in rat blood. Characterization, regional differences, and responses to oral and intravenous glucose.
    Berelowitz M; Kronheim S; Pimstone B; Shapiro B
    J Clin Invest; 1978 May; 61(5):1410-4. PubMed ID: 659602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pancreatic and gastric somatostatin release in response to intragastric and intraduodenal nutrients and HCl in the dog.
    Schusdziarra V; Harris V; Conlon JM; Arimura A; Unger R
    J Clin Invest; 1978 Sep; 62(3):509-18. PubMed ID: 690183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Somatostatin-like immunoreactivity in chemically sympathectomized dogs.
    Schusdziarra V; Rouiller D; Harris V; Dey R; Unger RH
    Horm Metab Res; 1980 Dec; 12(12):656-60. PubMed ID: 6110628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin on fasting and meal-stimulated somatostatin-like immunoreactivity in noninsulin-dependent diabetes mellitus: evidence for more than one mechanism of action.
    Gutniak M; Grill V; Efendić S
    J Clin Endocrinol Metab; 1986 Jan; 62(1):77-83. PubMed ID: 2866196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the pancreas to circulating somatostatin-like immunoreactivity in the normal dog.
    Taborsky GJ; Ensinck JW
    J Clin Invest; 1984 Jan; 73(1):216-23. PubMed ID: 6140271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of low-dose somatostatin infusion on pancreatic and gastric endocrine function in lean and obese nondiabetic human subjects.
    Schusdziarra V; Lawecki J; Ditschuneit HH; Lukas B; Maier V; Pfeiffer EF
    Diabetes; 1985 Jun; 34(6):595-601. PubMed ID: 2861127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a role of splanchnic somatostatin in the homeostasis of ingested nutrients.
    Schusdziarra V; Harris V; Arimura A; Unger RH
    Endocrinology; 1979 Jun; 104(6):1705-8. PubMed ID: 446390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release of somatostatin-like immunoreactivity from the lower gut.
    Rouiller D; Schusdziarra V; Conlon JM; Harris V; Unger RH
    Gastroenterology; 1979 Oct; 77(4 Pt 1):700-3. PubMed ID: 467926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pancreatic and gastric release of somatostatinlike immunoreactivity during intestinal phase of a meal.
    Schusdziarra V; Rouiller D; Pietri A; Harris V; Zyznar E; Conlon JM; Unger RH
    Am J Physiol; 1979 Dec; 237(6):E555-60. PubMed ID: 517653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of endogenous somatostatin-like immunoreactivity and synthetic somatostatin in dog plasma.
    Conlon JM; Srikant CB; Ipp E; Schusdziarra V; Vale W; Unger RH
    J Clin Invest; 1978 Dec; 62(6):1187-93. PubMed ID: 748373
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin inhibits somatostatin-like immunoreactivity release stimulated by intragastric HCl.
    Rouiller D; Schusdziarra V; Unger RH
    Diabetes; 1981 Sep; 30(9):735-8. PubMed ID: 6114888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the hormonal status of somatostatin in man.
    Zyznar ES; Pietri AO; Harris V; Unger RH
    Diabetes; 1981 Oct; 30(10):883-6. PubMed ID: 6115787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of bombesin upon plasma somatostatin-like immunoreactivity, insulin and glucagon in normal and chemically sympathectomized dogs.
    Schusdziarra V; Rouiller D; Harris V; Pfeiffer EF; Unger RH
    Regul Pept; 1980 Oct; 1(2):89-96. PubMed ID: 6114514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of histamine H2-receptors in gastric and pancreatic release of somatostatin-like immunoreactivity during the gastric phase of meal.
    Schusdziarra V; Rouiller D; Harris V; Unger RH
    Regul Pept; 1981 Feb; 1(5):353-63. PubMed ID: 7255767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposing actions of glucagon and insulin on splanchnic d cell function.
    Kawai K; Unger RH
    J Clin Invest; 1983 Mar; 71(3):721-5. PubMed ID: 6131079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of 2-deoxy-D-glucose on plasma somatostatin levels in conscious dogs.
    Wasada T; Dobbs RE; Harris V; Unger RH
    Endocrinology; 1981 Apr; 108(4):1222-7. PubMed ID: 6110537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response of plasma somatostatin-like immunoreactivity to the administration of alloxan in dogs.
    Schusdziarra V; Harris V; Unger R
    Horm Metab Res; 1979 Aug; 11(8):457-9. PubMed ID: 499995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma somatostatin 28 increases in response to feeding in man.
    Polonsky KS; Shoelson SE; Docherty HM
    J Clin Invest; 1983 May; 71(5):1514-8. PubMed ID: 6133883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.